Active Transferrin (TF) Canis familiaris; Canine (Dog) Active protein

TRF; Siderophilin; Serotransferrin; Beta-1 metal-binding globulin

No quotes Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Point7.4
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Transferrin (TF) Packages (Simulation)
  • Active Transferrin (TF) Packages (Simulation)
  • APC036Ca61.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Transferrin (TF) is one of members of anion-binding superfamily of proteins. It is synthesized as a 698 amino acid (aa) precursor, which is mainly in the liver and is present in high concentrations in the bloodstream.TF plays a fundamental role in iron metabolism, protecting tissues from the potentially harmful effects of free iron, which can generate reactive oxygen species and cause oxidative damage. To test the effect of TF on cell proliferation, HepG2 cells were seeded into triplicate wells of 96-well plates and allowed to attach, replaced with various concentrations of recombinant dog TF. After incubated for 72h, cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10 µl of CCK-8 solution was added to each well of the plate, then the absorbance at 450 nm was measured using a microplate reader after incubating the plate for 1-4 hours at 37 ℃. Cell viability was assessed by CCK-8 assay after incubation with recombinant dog TF for 72h. The result was shown in Figure 1. It was obvious that TF significantly increased cell viability of HepG2 cells. The ED50 of recombinant dog TF is 0.292 μg/ml.

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical SignificancePubMed: PMC3754973
  • The Labile Iron Pool in Monocytes Reflects the Activity of the Atherosclerotic Process in Men with Chronic Cardiovascular Diseasepubmed:27782743
  • Putative salivary biomarkers useful to differentiate patients with fibromyalgiaPubmed:29654921
  • Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese PatientsPubmed: 30486327
  • Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria
  • New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemiaPubmed: 30792208

Recommend products